2009 ASH Distinguished Scientist Award

One ASH Distinguished Scientist Award is given each year depending on the field to which the award recipient has made his or her contribution. The purpose of the ASH Distinguished Scientist Award is to honor a scientist or physician for outstanding achievements in the field of hypertension. The award recipient receives a framed certificate and a $10,000 honorarium. The awardee is also requested to present a 30- minute lecture during the awards session at the ASH Annual Meeting and will receive complimentary registration and reimbursement for travel expenses and hotel accommodations.

Sponsors who wish to have their candidates nominated for an award must be current ASH members and provide the following information:

	Complete name, address, phone, and fax numbers of the nominee
	A signed letter of nomination from the sponsor and at least one additional supporting letter. The letters should clearly articulate the major contributions of the nominee to the field of hypertension.
	A current curriculum vitae of candidate.

A candidate may be nominated by one or more different individuals within the same year. Previous winners of the ASH Distinguished Scientist Award and members of the ASH Scientific Awards Committee are not eligble for nomination.

The Awards Committee will assess the candidates’ overall scientific contributions and their impact on the field of hypertension.

The ASH Distinguished Scientist Award recipient receives an award within one of these five categories:

William Harvey Award
This award is named for scientist William Harvey (1578- 1657) who developed the first accurate account of how the heart and circulatory system operated.

Richard Bright Award
This award is named for Richard Bright, (1789- 1858). Often referred to as the Father of Nephrology, Dr. Bright is well known for his great contributions to the study of the kidney.

Robert Tigerstedt Award
Robert Tigerstedt (1853- 1923) is recognized as an outstanding contributor to both endocrinology and circulation. He is best known for his discovery of the renin- angiotensin system.

Harriet Dustan Award
This award is named for Harriet P. Dustan, MD (1920 - 1999). Dr. Dustan made many contributions to hypertension in her career of over 40 years. These include her clinical and investigative achievements, especially the concept of essential hypertension as a multifactoral disease of pressure regulation. Dr. Dustan explored many of the pressor mechanisms and related new knowledge to therapeutic concepts.

Irvine Page Award
This award is named for Irvine H. Page, MD (1901 - 1991). In Dr. Page’s long research career he made endless discoveries and contributions to the treatment and espousal of hypertension. He may be bast known for the discovery and characterization of angiotensin, the identification of serotonin, and the mosaic theory.

For more information, please contact:
Ashley Buron, Program Coordinator
American Society of Hypertension
148 Madison Avenue, Fifth Floor
New York, NY 10016
Phone: 212.696.9099
Fax: 212.696.0711
E-mail: awards@ash-us.org

2009 ASH Distinguished Scientist Award Winner

The American Society of Hypertension is pleased to announce the winner of the ASH Robert Tigerstedt Award:

An internationally recognized leader in endocrinology, Dr. Carey has focused his clinical interest in cardiovascular and renal endocrinology and his research on the hormonal control of blood pressure and hypertension. Major discoveries include the identification and characterization of the intrarenal renin-angiotensin system as an independent tissue hormonal system, the expression and functions of the dopamine D1-like receptor family and the angiotensin type-2 (AT2 ) receptor and the role of renal cyclic GMP in the control of sodium excretion and blood pressure. Dr. Carey documented the first case of ectopic corticotropin releasing factor as a cause of Cushing's syndrome.

Dr. Carey served as James Carroll Flippin Professor of Medical Science and Dean of the University of Virginia School of Medicine from 1986 to 2002. During his tenure as Dean, Dr. Carey founded departments of health evaluation sciences, emergency medicine, radiation oncology and physical medicine and rehabilitation. He initiated a clinical trials center, a biomedical ethics center, a humanities in medicine program, a generalist medicine program, a program in international health, a digestive health center of excellence and a clinical cancer center. He developed new research centers in cell signaling, structural biology, retrovirology, reproduction, immunology and cardiovascular sciences. Dr. Carey constructed four new research buildings and a conference center an developed architectural plans and funding for a fifth research building for the School of Medicine. During his 16 years as Dean, National Institutes of Health (NIH) funds quintupled, private fund raising increased from $ 2.7 million to $40 million per year and 60 endowed professorships were established. The School of Medicine markedly strengthened its basic medical sciences, interdisciplinary research centers and programs and University-wide collaboration in research and teaching during his deanship.

Born in Lexington, Kentucky, Dr. Carey received his medical degree from Vanderbilt University in 1965. He completed his residency in medicine at the New York Hospital-Cornell Medical Center and fellowships in endocrinology with Dr. Grant W. Liddle at Vanderbilt and in hypertension with Professor Sir Stanley Peart at St. Mary's Hospital Medical School in London, England.

Dr. Carey began his career in academic medicine at the University of Virginia in 1973. As Head of the Division of Endocrinology and Metabolism from 1978-1986, he developed the program into one of the best in the country (highest ranking #5; current ranking #8 by U.S. News).

Highly respected by his peers, Dr. Carey is author or co-author of over 300 scientific articles and author/editor of three books. He maintained a productive NIH-funded research program throughout his deanship and has been a strong advocate for biomedical research nationally. He has been a member of the National Research Resources Advisory Council (1994-98), has chaired two strategic planning processes (1997 and 2003) for the National Center for Research Resources, has been a member of the Association of American Medical Colleges (AAMC) Advisory Panel on Research (1998-2003) and a member of the Clinical Research Task Force of the AAMC. For The Endocrine Society, he has been a member of Council, the Finance Committee, the Research Committee and The Hormone Foundation Board of Directors and has chaired the Development Committee. Dr. Carey is President of The Endocrine Society. For the American Heart Association (AHA), Dr. Carey is Past-Chair of the Council for High Blood Pressure Research and of the AHA Council Operations Committee. Dr. Carey is currently funded with three major research grants from the NIH for both laboratory and patient-oriented investigation in hypertension.

Dr. Carey is a member of the Institute of Medicine of the National Academy of Sciences, the Association of American Physicians and the American Society for Clinical Investigation, has been President of the American Clinical and Climatological Association, Dr. Carey is recipient of the Distinguished Alumnus Award from Vanderbilt University, the Distinguished Achievement Award of the New York Hospital/Cornell Medical Alumni Council, the Walter Reed Distinguished Achievement Award of the University of Virginia Medical Alumni Association, the Lifetime Achievement Award of the Consortium of Southeast Hypertension Centers and the Irving Page/Alva Bradley Lifetime Achievement Award of the Council for High Blood Pressure Research of the American Heart Association. He is a Fellow of the Royal College of Physicians of Ireland, and a Master of the American College of Physicians (ACP). Dr. Carey has received an Honorary Citation from Governor Mark R. Warner (2002) and a Joint Resolution commending him from the General Assembly of the Commonwealth of Virginia (2004). He received the Laureate Award of the Virginia Chapter of the ACP (2004), the Distinguished Physician Award of The Endocrine Society (2005), and the American Heart Association Scientific Councils Distinguished Achievement Award (2008).

The Dean Robert M. Carey Award, initiated in 2003 by University of Virginia medical students, honors a member of the second year class exhibiting qualities of leadership, scholarship and building a sense of community during the first two years of medical school. The Carey, Marshall, Thorner Scholars Research Day of the Department of Medicine was initiated in 2007. In 2003, Dr. Carey received the Thomas Jefferson Award, the highest honor bestowed by the University of Virginia, for transforming academic medicine at the University.